ctrl K

SpringWorks Therapeutics ... (SWTX)

NASDAQ: SWTX · Real-Time Price · USD

46.24

-0.06 (-0.13%)

At close: May 01, 2025, 3:59 PM

46.18

-0.13%

After-hours: May 01, 2025, 04:18 PM EDT

SpringWorks Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	191.59M	5.45M	6.15M	n/a	35M	n/a	n/a	n/a
Cost of Revenue	12.55M	422K	1.9M	490K	349K	192K	17.33K	3.18K
Gross Profit	179.04M	5.03M	4.25M	-490K	34.65M	-192K	-17.33K	-3.18K
Operating Income	-278.13M	-343.01M	-280.67M	-173.47M	-46.32M	-59.24M	-18.49M	-4.66M
Interest Income	26M	22.95M	6.15M	698K	1.33M	3.55M	678K	63K
Pretax Income	-258.13M	-325.1M	-277.42M	-173.91M	-45.57M	-58.31M	-17.81M	-4.64M
Net Income	-258.13M	-325.1M	-274.16M	-173.21M	-44.24M	-54.76M	-17.81M	-4.64M
Selling & General & Admin	256.65M	197.55M	134.55M	71.79M	29.46M	16.69M	8.59M	1.86M
Research & Development	200.52M	150.49M	146.12M	101.68M	51.86M	42.55M	9.9M	2.8M
Other Expenses	n/a	n/a	-138K	-152K	25K	n/a	n/a	n/a
Operating Expenses	457.17M	348.04M	280.67M	173.47M	81.32M	59.24M	18.49M	4.66M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3.73M
Cost & Expenses	469.72M	348.46M	280.67M	173.47M	81.32M	59.24M	18.49M	4.66M
Income Tax Expense	n/a	n/a	-3.26M	-698K	-1.33M	-3.55M	678K	-2
Shares Outstanding (Basic)	74.13M	63.12M	53.29M	48.5M	43.3M	43.01M	22.2M	43.23M
Shares Outstanding (Diluted)	74.13M	63.12M	53.29M	48.5M	43.3M	43.01M	22.2M	43.23M
EPS (Basic)	-3.48	-5.15	-5.14	-3.57	-1.02	-1.27	-0.8	-0.11
EPS (Diluted)	-3.48	-5.15	-5.14	-3.57	-1.02	-1.27	-0.8	-0.11
EBITDA	-278.13M	-341.35M	-280.67M	-172.98M	-45.98M	-59.05M	-18.47M	-4.64M
EBIT	-278.13M	-343.01M	-277.42M	-173.47M	-46.32M	-59.24M	-17.81M	-4.64M
Depreciation & Amortization	n/a	1.67M	1.9M	490K	349K	192K	17.33K	3.18K